Covid-19 Content:
Access to outpatient genetic testing during COVID-19

Genetic testing plays an extremely important role in getting answers about neurologic conditions and continues to be a useful treatment tool — both during COVID-19 and as we move into a new normal.

Marshall Summar, MD, is the director of the Rare Disease Institute at the Children’s National Medical Center and Mike Graglia is a parent and managing director of the SynGAP Research Fund. In this video, they discuss why genetic testing is important and how to access it as an outpatient.

Watch the Video